Idarucizumab
- IVIdarucizumabPraxbind
Mechanism of Action
- A monoclonal antibody that strongly binds to dabigatran, preventing its effect on prothrombin.
Clinical Use
- Indications
- Reversal of dabigatran prior to emergency surgery
- Reversal of dabigatran in the event of life-threatening or uncontrolled bleeding
Adverse Effects
- No specific adverse reactions identified in clinical trials.